Quick Answer
Arcus Biosciences, Inc. reported Long Term Debt of $99.00 million for the year ending 2025.
- Arcus Biosciences, Inc. showed an increase of +106.3% in Long Term Debt from 2024 to 2025.
- This data is from Arcus Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $47.00 million | Q1 2025: $48.00 million | Q2 2025: $97.00 million | Q3 2025: $98.00 million.
- Historical annual values: Fiscal year 2025: $99.00 million | Fiscal year 2024: $48.00 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: